Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial

Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial

Abstract Background Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disorder characterized by the development of numerous benign tumors. Renal angiomyolipoma (RAML) occur in up to 80% of TSC patients, which is a leading cause of TSC-related death in adult patients. The aim of t...

Full description

Bibliographic Details
Main Authors: Yi Cai, Hao Guo, Wenda Wang, Hanzhong Li, Hao Sun, Bing Shi, Yushi Zhang
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Angiomyolipoma
Tuberous sclerosis complex
Everolimus
Treatment outcome
Safety
Online Access:http://link.springer.com/article/10.1186/s13023-018-0781-y

Internet

http://link.springer.com/article/10.1186/s13023-018-0781-y

Similar Items